The effectiveness of endoscopic sphenopalatine ganglion block in management of postoperative pain after septal surgery

Background This study evaluated the effect of bilateral endoscopic sphenopalatine ganglion block (SPGB) for management of postoperative pain in patients undergoing septoplasty. Methods Sixty septoplasty patients (51.7% male, 48.3% female, aged 18 to 45 years) were randomly assigned to general anesth...

Full description

Saved in:
Bibliographic Details
Published in:International forum of allergy & rhinology 2019-12, Vol.9 (12), p.1521-1525
Main Authors: Ekici, Nur Yücel, Alagöz, Sedat
Format: Article
Language:English
Subjects:
analgesia
Analgesics
Anesthesia
Bupivacaine
Endoscopy
Nausea
Pain
Pain management
Postoperative period
septoplasty
sphenopalatine ganglion block
Surgery
Vomiting
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background This study evaluated the effect of bilateral endoscopic sphenopalatine ganglion block (SPGB) for management of postoperative pain in patients undergoing septoplasty. Methods Sixty septoplasty patients (51.7% male, 48.3% female, aged 18 to 45 years) were randomly assigned to general anesthesia (GA) alone (control) (n = 30) or GA plus endoscopic SPGB (n = 30). Demographic data, duration of surgery, blood loss, postoperative visual analogue scale (VAS) pain scores (upon arrival at the postanesthesia care unit [PACU] and 2, 6, 12, and 24 hours after surgery), overall analgesic usage (end of 24 and 168 hours after surgery), overall satisfaction with the pain control (end of 24 and 168 hours after surgery), and complications (bleeding, nausea and vomiting, and visual disturbance) were recorded. Results Pain scores upon arrival to the PACU and 2, 6, 12, and 24 hours after surgery were significantly lower in the SPGB group compared to the control group (p < 0.001). Moreover, the SPGB group had significantly lower analgesic requirements and higher satisfaction scores with their pain control at the end of 24 and 168 hours after surgery compared to the control group (p < 0.001). The 2 groups significantly differed in terms of intraoperative blood loss (p = 0.024), and surgery time was longer in the SPGB group compared to the control group (p < 0.001). Conclusion SPGB with bupivacaine is a safe and effective method to reduce pain after septoplasty, and it is a cost‐effective alternative to high doses of analgesics.
ISSN:2042-6976
2042-6984
DOI:10.1002/alr.22411